Spyre Therapeutics (SYRE) Q2 2022 Earnings

4AugExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-9.25
-6.26
-3.27
-0.28

Details

Expected EPS
-0.3178
Actual EPS
-6.75
Surprise EPS
-6.43
Surprise Percent
+2,023.98%

Description

Spyre Therapeutics (SYRE) has reported earnings of -6.75 per share for Q2 2022.

0 Comments

Share your thoughts